Literature DB >> 33441123

Clinical relevance of routine transvaginal ultrasound in women referred with pelvic organ prolapse.

Lone Pedersen1,2,3, Marianne Glavind-Kristensen4, Pinar Bor5,4.   

Abstract

BACKGROUND: The aim of this study was to investigate the prevalence of incidental findings on transvaginal ultrasound scan in women referred with pelvic organ prolapse by a general practitioner and to investigate which further examinations and treatments were performed as a result of these findings.
METHODS: This was a retrospective cohort study that investigated women with pelvic organ prolapse referred to the outpatient urogynaecological clinics at Randers Regional Hospital and Aarhus University Hospital, Denmark.
RESULTS: A total of 521 women were included and all of them were examined with a routine transvaginal ultrasound scan and a gynaecological examination. Prolapse symptoms only and no specific indication for transvaginal ultrasound scan were seen in 507 women (97.3%), while 14 women (2.7%) received scans on indication. Among the latter women, five (35.7%) had cancer. In the women with solely prolapse symptoms, 59 (11.6%) had incidental findings on transvaginal ultrasound scan, but all were benign. However, two patients were later diagnosed with cancer unrelated to the initial ultrasound findings. The treatment was extended with further examinations not related to POP in 19 of the women (32.2%) with incidental ultrasound findings.
CONCLUSION: The prevalence of incidental ultrasound findings was not high in the women referred with pelvic organ prolapse and no additional symptoms, and all these findings were benign. However, it should be considered that these findings resulted in further investigations and changes to the patients' initial treatment plans. A meticulous anamnesis and digital vaginal examination are crucial to rule out the need for vaginal ultrasound.

Entities:  

Keywords:  Incidental finding; Pelvic organ prolapse; Ultrasonography

Mesh:

Year:  2021        PMID: 33441123      PMCID: PMC7805096          DOI: 10.1186/s12905-021-01173-z

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  15 in total

1.  Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse.

Authors:  Anna C Frick; Mark D Walters; Kathleen S Larkin; Matthew D Barber
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

Review 2.  Updated recommendations on ultrasonography in urogynecology.

Authors:  R Tunn; G Schaer; U Peschers; W Bader; A Gauruder; E Hanzal; H Koelbl; D Koelle; D Perucchini; E Petri; P Riss; B Schuessler; V Viereck
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-10-16

Review 3.  Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis.

Authors:  Clare J Reade; John J Riva; Jason W Busse; Charlie H Goldsmith; Laurie Elit
Journal:  Gynecol Oncol       Date:  2013-06-30       Impact factor: 5.482

4.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

5.  Uterus conserving prolapse surgery--what is the chance of missing a malignancy?

Authors:  Arasee Renganathan; Robin Edwards; Jonathan R A Duckett
Journal:  Int Urogynecol J       Date:  2010-02-05       Impact factor: 2.894

6.  Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms?

Authors:  Robert E Gutman; Daniel E Ford; Lieschen H Quiroz; Stuart H Shippey; Victoria L Handa
Journal:  Am J Obstet Gynecol       Date:  2008-10-01       Impact factor: 8.661

7.  Is transvaginal ultrasound a worthwhile investigation for women undergoing vaginal hysterectomy?

Authors:  S Srikrishna; D Robinson; L Cardozo; J Yazbek; D Jurkovic
Journal:  J Obstet Gynaecol       Date:  2008-05       Impact factor: 1.246

Review 8.  Managing women with post-menopausal bleeding.

Authors:  Elisabeth Epstein; Lil Valentin
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-02       Impact factor: 5.237

9.  Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity.

Authors:  Susan L Hendrix; Amanda Clark; Ingrid Nygaard; Aaron Aragaki; Vanessa Barnabei; Anne McTiernan
Journal:  Am J Obstet Gynecol       Date:  2002-06       Impact factor: 8.661

10.  Results from four rounds of ovarian cancer screening in a randomized trial.

Authors:  Edward Partridge; Aimee R Kreimer; Robert T Greenlee; Craig Williams; Jian-Lun Xu; Timothy R Church; Bruce Kessel; Christine C Johnson; Joel L Weissfeld; Claudine Isaacs; Gerald L Andriole; Sheryl Ogden; Lawrence R Ragard; Saundra S Buys
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.